Day Zero Diagnostics to Be Acquired by bioMérieux
bioMérieux is acquiring the assets of Day Zero Diagnostics to enhance its capabilities in NGS and rapid infectious disease diagnostics.
Read MorePosted by Chris Wolski | Jun 17, 2025 | Company News |
bioMérieux is acquiring the assets of Day Zero Diagnostics to enhance its capabilities in NGS and rapid infectious disease diagnostics.
Read MorePosted by Chris Wolski | Jun 13, 2025 | Infectious Diseases |
A new AI-driven, non-DNA-based nanopore test can rapidly identify live viruses with high sensitivity by analyzing their unique signatures.
Read MorePosted by Chris Wolski | Jun 9, 2025 | Gastrointestinal Infections |
Australian researchers have developed a groundbreaking blood test that can accurately diagnose celiac disease.
Read MorePosted by Chris Wolski | Jun 6, 2025 | Molecular Diagnostic Analyzers |
AMDI has completed a successful clinical study of its Fast PCR-based Mini Respiratory Panel and earned MDSAP certification.
Read MorePosted by Chris Wolski | Jun 5, 2025 | Sexually Transmitted Diseases |
Linear Diagnostics has secured funding to finalize and clinically validate a rapid, accurate STI diagnostic platform.
Read More